Quantcast

Latest TransCelerate BioPharma Inc. Stories

2014-09-22 12:28:43

ELLICOTT CITY, Md., Sept. 22, 2014 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) has announced that its Good Clinical Practice (GCP) training, provided to all SCRS member employees, is now officially recognized by TransCelerate BioPharma Inc.'s members. Among TransCelerate's numerous members are SCRS Global Impact Partner companies AstraZeneca, Lilly, GlaxoSmithKline, Pfizer, Roche, and Sanofi. This landmark development is the result of considerable effort on behalf...

2014-09-17 08:30:48

Two Manuscripts Appear in Drug Information Association's Therapeutic Innovation & Regulatory Science PHILADELPHIA, Sept. 17, 2014 /PRNewswire/ -- TransCelerate BioPharma Inc. ("TransCelerate") announced today the publication of its two most recent manuscripts on risk-based site monitoring ("Risk-Based Monitoring" or "RBM"), developed jointly by its 19 member companies. Both manuscripts have been accepted and published through the Drug Information Association's Therapeutic Innovation...

2014-09-16 23:07:26

CDISC standards now electronically accessible by computer applications Austin, Texas (PRWEB) September 16, 2014 The Clinical Data Interchange Standards Consortium (CDISC) is pleased to announce the official launch of CDISC eSHARE. For the first time, CDISC metadata standards in multiple formats are now electronically accessible by computer applications through an integrated system. eSHARE enables standards-based automation, which is key to increasing ROI from standards implementation....

2014-09-02 08:31:36

PHILADELPHIA, Sept. 2, 2014 /PRNewswire/ -- TransCelerate BioPharma Inc. ("TransCelerate") today announced that it has developed a recommended approach for protecting personal data in Clinical Study Reports (CSRs) that are shared with researchers, patients and others. The document describes an approach to apply when redacting or removing personal information from CSRs and other related clinical trial documents, and is available here. The goal of the TransCelerate CSR Redaction...

2014-07-24 08:31:56

The Shared Investigator Platform, Built as an Industry Utility, Will Help Accelerate the Development of New Medicines TEANECK, N.J., July 24, 2014 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a first-of-its-kind, subscription-based platform that will transform the way clinical sites collaborate with...

2014-06-16 08:29:45

PHILADELPHIA, June 16, 2014 /PRNewswire/ -- TransCelerate BioPharma Inc. ("TransCelerate") is launching two new global initiatives enabled by broad participation and collaboration across the global research and development (R&D) community: develop a position on the best and most efficient methods for redacting privacy information found in clinical study reports and an approach for the anonymization of patient level data shared with the broader healthcare community; and develop a...

2014-05-06 23:01:36

Industry leaders in R&D will examine accomplishments, progress and 2014 line extensions. WASHINGTON (PRWEB) May 06, 2014 Susan Cantrell, senior vice president and managing director for DIA Americas, will chair the panel discussion “Collaboration in R&D: What’s New for TransCelerate BioPharma?” during DIA’s 2014 50th Annual Meeting at the San Diego Convention Center from June 15 to 19. TransCelerate BioPharma Inc. is a nonprofit organization of industry leaders that aims...

2014-04-23 12:30:25

Program Will Drive Research Collaboration, Enhance Site Sustainability ELLICOTT CITY, Md., April 23, 2014 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) is proud to announce the launch of its newest initiative, the Site Advocacy Group (SAG). SCRS is honored to have TransCelerate BioPharma Inc. ("TransCelerate") as its SAG partner. The SAG is a landmark industry initiative that enables clinical investigators and site professionals to interact directly with senior...

2014-02-25 08:33:10

PHILADELPHIA, Feb. 25, 2014 /PRNewswire/ -- TransCelerate BioPharma Inc. ("TransCelerate") today announced the appointment of Annalisa Jenkins, MBBS, MRCP, Executive Vice President and Head of Global Research and Development at Merck Serono (biopharma division of Merck KGaA, Darmstadt, Germany), as Chair of its Board of Directors, effective immediately. Dr. Jenkins, who previously served as a member of the Board of Directors, will work closely with TransCelerate CEO Dr. Dalvir Gill to...

2014-01-30 08:32:11

PHILADELPHIA, Jan. 30, 2014 /PRNewswire/ -- In its continued effort to modernize and streamline the way clinical trials are conducted and monitored, TransCelerate BioPharma Inc. ("TransCelerate") is providing the first update to its position paper outlining a methodology for risk-based site monitoring ("Risk-Based Monitoring" or "RBM") released in June 2013. The update is a result of continued refinement of the position paper's concepts and assessing the experiences and lessons...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related